Frontiers | The impact of COVID-19 on accelerating of immunosenescence and brain aging
COVID-19 induces chronic inflammation, immunosenescence, and neuroinflammation.
NIH study on 7 Neuro-PASC patients (ages 42-63) found 71% of initial abnormalities, like autonomic and immunologic issues, persisted after 1 year.
Persistent signs include central catecholamine deficiency and MRI changes.